Clinical Trial Update: Comparison of Immune Response Following Surgical Management of Renal Tumors

View source ↗

Summary

The Emory University–sponsored trial evaluating immune response after surgical management of renal tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Emory University | Conditions: Kidney Cancer | Status: TERMINATED